Zolmitriptan Tablet, Film Coated
NDC Package 46708-462-06

11-digit billing NDC: 46708046206

Package Information

Zolmitriptan tablets is zolmitriptan is indicated for the acute treatment of migraine with or without aura in adults Limitations of UseOnly use zolmitriptan if a clear diagnosis of migraine has been established. This formulation utilizes a tablet, film coated delivery system. Marketed by Alembic Pharmaceuticals Limited, this product is identified by NDC 46708-462 and is authorized under FDA application ANDA204232.

Identification & Billing

NDC Package Code
46708-462-06
Package Description
6 TABLET, FILM COATED in 1 CARTON
Product Code
11-Digit Billing Format
46708046206
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Zolmitriptan
Non-Proprietary Name
Zolmitriptan
Substance Name
Zolmitriptan
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Zolmitriptan is indicated for the acute treatment of migraine with or without aura in adults Limitations of UseOnly use zolmitriptan if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan is administered to treat any subsequent attacks. Zolmitriptan is not indicated for the prevention of migraine attacks. Safety and effectiveness of zolmitriptan have not been established for cluster headache.

Regulatory & Marketing

Labeler Name
Alembic Pharmaceuticals Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA204232
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-04-2016
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 46708-462-06 identifies a specific commercial package of 6 tablet, film coated in 1 carton of Zolmitriptan, a human prescription drug labeled by Alembic Pharmaceuticals Limited. This tablet, film coated is formulated for oral use and contains zolmitriptan as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alembic Pharmaceuticals Limited on January 04, 2016. The current certification is valid through December 31, 2027.

How is this Alembic Pharmaceuticals Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 46708046206. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
46708-462-06
11-Digit CMS (5-4-2)
46708-0462-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.